Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -6.22% | +78.50% |
2019 | Argos Therapeutics, Inc. Went Out of Business | CI |
2019 | First Amended Liquidation Plan Approved for Argos Therapeutics, Inc. | CI |
Sales 2016 | 945K 78.93M | Sales 2017 | 1.9M 159M | Capitalization | 13.18M 1.1B |
---|---|---|---|---|---|
Net income 2016 | -53M -4.42B | Net income 2017 | -40M -3.34B | EV / Sales 2016 | 200 x |
Net cash position 2016 | 13.11M 1.09B | Net Debt 2017 | 4.27M 356M | EV / Sales 2017 | 9.19 x |
P/E ratio 2016 |
-2.96
x | P/E ratio 2017 |
-0.22
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 88.73% |
1st Jan change | Capi. | |
---|---|---|
+78.50% | 567K | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-13.15% | 32.81B | |
+52.41% | 25B | |
-17.35% | 15.29B | |
-42.45% | 11.61B | |
-10.48% | 11.49B | |
+6.14% | 8.98B | |
-7.72% | 8.23B |
- Stock Market
- Equities
- ARGSQ Stock